相关实验视频

Updated: Jun 14, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

对孕激素和雌激素的不成比例分析表明脑膜瘤风险增加

Connor Frey¹, Mahyar Etminan²

¹Department of Medicine, University of British Columbia, 2194 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

|May 17, 2025

概括

某些激素疗法显著增加脑膜瘤风险. 孕激素和雌激醇的风险最高,突出了激素处方中个性化风险评估的必要性.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
药物监督药物监督药物监督

背景情况:

激素避孕药被广泛使用.
激素,包括孕激素和雌激素,可能会影响瘤增殖.
脑膜瘤是可以受到荷尔蒙因素影响的瘤.

研究的目的:

调查特定的孕激素和雌激素与脑膜瘤风险之间的关联.
为了澄清激素治疗和脑膜瘤发展之间的关系.
提供有关激素避孕药的临床决策的信息.

主要方法:

分析来自FDA不良事件报告系统 (FAERS) 的数据.
使用不成比例分析来评估风险关联.
计算报告概率比率 (ROR) 和95%的置信区间 (CI).

主要成果:

孕激素中,孕激素 (ROR 2620.65) 和孕激素 (ROR 871.48) 的脑膜瘤风险最高.
在雌激素中,雌激醇 (ROR 17.79) 和乙雌激醇 (ROR 7.44) 的风险最高.
二和结合性雌激素显示中度至较低的风险;利醇,雌激素和梅斯特兰醇显示潜在的较低风险.

结论:

在不同的激素疗法中,脑膜瘤风险存在显著差异.
某些孕激素和雌激素与明显更高的脑膜瘤风险有关.
个性化风险评估对于处方荷尔蒙疗法至关重要,特别是对于基于荷尔蒙的避孕药.

关键词:

雌激素是一种雌激素.公平的人是公平的.激素治疗是一种激素治疗.阴道瘤是发生在阴道上的人.药物监督药物监督药物监督孕激素是一种前原体.

更多相关视频

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

相关概念视频

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...